Stock Scorer

Basel Medical Group Ltd (BMGL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD. Every figure as a table ›

Revenue Annual

0 3.5M 7M 10.5M FY25: 8.9M FY25

Net Income Annual

-9M -6M -3M 0 3M 6M 9M FY25: -8.4M FY25

Operating Cash Flow Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY25: -3.2M FY25

Free Cash Flow Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY25: -3.6M FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 7M 14M 21M FY24: 16.2M FY25: 18.8M FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS Annual

-0.60 -0.40 -0.20 0.00 0.20 0.40 0.60 FY25: -0.45 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for BMGL: Gross Profit, Operating Income, Cost of Revenue. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.